CASES DEATHS CASES DEATHS
December 2020 19,111,443 341,149 2,120,610 24,241
January 26,185,362 441,319 3,310,949 40,702
February 28,602,101 513,137 3,563,578 51,953
March 30,459,874 552,072 3,668,277 59,240
April 32,225,012 574,280 3,742 115 62,078
May 33,261,284 594,468 3,789,227 63,247
UPDATED WEEKLY - Last updated on 27 June, 2021 7:30 pm PST, John Hopkins Corona Virus Dashboard and Worldometer
John Hopkins Worldometer
Recovered - Recovered - 166,373,962
POPULATION - is 332,918,463 as of 27 June, 7:30 pm PST, based on Census U.S. and World Population Clock.
Cases in the U.S.
Recovered - Recovered - 28,927,335
Cases in California
Recovered - Recovered - 2,072,518
2021 unemployment numbers are hovering around 5.8% as of May 2021.
06/27/2021 Cases (WHO) Deaths (WHO) Recovered (WHO)
**reporting information is limited, reduced testing and increased cases
United States progress Updated as of 27 June 2021, 7:30 pm
State Progress Updated as of 27 June 2021, 7:30 pm
. 1st dose 2nd dose % fully Vaccinated
** Last on vaccine tracker
While a COVID-19 vaccine is available for adults, the kid version is still in clinical trials. But do children really need one? In short, yes. Children under 21 make up 25% of the U.S. population. If many of them get a vaccine, the chance of herd immunity goes up. If enough people are resistant to the cause of a disease, such as a virus or bacteria, it has no one to infect.
Vaccine Trials for Children.
The FDA granted emergency use authorization for the Pfizer COVID-19 vaccine for ages 16 and older. The Moderna and Janssen vaccines are for ages 18 and older. The vaccines still mainly target adults, but some states also prioritize older children with intellectual, developmental disabilities or other medical conditions.
Pfizer finished a clinical trial for children 12-15 years old and will soon start trials for younger ages. Moderna recently began vaccine studies for children 6 months to 11 years old and another for ages 12 to 17. Johnson & Johnson plans to start similar trials soon.
COVID-19 Vaccines for Children and Teens
Fewer children have been infected with COVID-19 compared to adults, but children can:
The CDC recommends teens 12 years and older should get a COVID-19 vaccination to help protect against the virus. Widespread vaccination is a critical tool to help stop the pandemic.
Children, ages 12 through 15, given the Pfizer-BioNTech COVID-19 vaccine had side effects similar to those experienced by the 16 and older age group. The side effects typically lasted 1 to 3 days. Other side effects were injection site pain after the second dose of the vaccine. However, some had no side effects.
Possible side effects
Your child may have some side effects, which are normal signs that their body is building protection.
On the arm where they get the shot:
Throughout the rest of your body:
Are there any children who shouldn't get the Pfizer-BioNTech COVID-19 vaccine?
There is no vaccine available to children younger than age 12. Clinical trials involving younger children are in progress. The vaccine shouldn’t be given to a child with a known history of a severe allergic reaction to any of its ingredients. If, this is the case, your child might be able to get another COVID-19 vaccine in the future.
Get a COVID-19 vaccine for your child as soon as you can.
MYOCARDITIS IN CHILDREN. How Does Myocarditis Affect the Heart?
According to the Mayo Clinic, “Myocarditis is an inflammation of the heart muscle or myocardium that affects the heart's electrical system by reducing the heart's ability to pump, causing rapid or abnormal heart rhythms or arrhythmias.
A viral infection usually causes myocarditis, but it can also result from a reaction to a drug or be part of a more general inflammatory condition. Signs and symptoms include chest pain, fatigue, shortness of breath and arrhythmias. Severe myocarditis weakens your heart causing the rest of your body to not get enough blood! Clots can form in your heart, leading to a stroke or heart attack.” The National Organization for Rare Disorders tells us that “In a majority of cases, the symptoms of myocarditis are preceded a few days to weeks by a flu-like illness.”
One feature that distinguishes myocarditis from other causes of heart failure is it often follows an upper respiratory or gastrointestinal infection and is due to a specific immune response against the heart itself.”
Who Is Most Susceptible to Myocarditis?
The National Organization for Rare Disorders indicates it is “most frequently diagnosed in younger adults between the ages of 20 and 40 years. Children seem to have a more severe presentation than adults with a greater proportion requiring temporary mechanical circulatory support. Men are generally more frequently affected than women, possibly due to effects of testosterone on the immune reaction to infection.
The relative frequency of more common age-related cardiovascular diseases such as coronary artery disease may lead to under diagnosis in the elderly. Certain forms of myocarditis, such as cardiac sarcoidosis, are more common in black than white persons in the U.S. However, most forms of myocarditis have no known ethnic predisposition.”
The heart is predominantly made out of muscle. Messing with your heart muscles can impair your heart’s blood pumping action and even eventually lead to heart failure. Inflammation can interfere with the electrical system that maintains this pumping action, leading to abnormal heart rhythms, otherwise known as arrhythmias.
MONOCLONAL ANTIBODIES. WHAT IS A MONOCLONAL ANTIBODY?
Your body naturally makes antibodies to fight infection. However, the body may not have antibodies designed to recognize a new virus like SARS-CoV-2, the virus that causes COVID-19. Monoclonal antibodies, or mAbs, are made in a laboratory to fight a particular infection. In this case, SARS-CoV-2 is given to patients directly with an infusion.
mAb treatment for COVID-19 is different from a vaccine. A vaccine triggers the body’s natural immune response, but can take weeks to develop enough antibodies and prevent some kinds of infection. Some vaccines for COVID-19 require two shots, so your body can develop its own immune response to the disease. But if you already have the virus, mAb treatment gives your body the antibodies it needs to protect itself.
WHAT CAN I EXPECT FROM TREATMENT (INFUSION)?
mAb treatment happens at an infusion center because the treatment is given through an intravenous (IV) infusion. Depending on the mAb treatment you receive, the process takes 2 to 3 hours. First, medical staff conducts a screening, then start an IV which delivers the mAbs to your body in just over an hour. Afterward, medical staff will have you stay at the infusion center for another hour to ensure you aren’t having an allergic reaction or other side effects. Reactions are rare, but the staff must observe you, then you’ll be released to go home.
It’s important to know that even if you start feeling better, you could still spread the virus for a while. You’ll need to isolate yourself until:
IMPORTANT: Follow your healthcare provider’s instructions. Your personal health history may require you to meet additional conditions. Also, if you start to feel worse, don’t hesitate to seek medical care.
CAN ANTIBODY TREATMENT MAKE ME SICK?
Antibody treatments don’t contain live SARS-CoV-2, so there’s no risk you’ll get COVID-19 from mAb treatment. However, antibody treatment may have side effects:
These are not all the possible side effects of antibody treatment. Serious and unexpected side effects may happen. Some possible risks from antibody treatment are:
mAb treatments for COVID-19, like other treatments authorized for emergency use by the U.S. Food and Drug Administration, are still being studied, so it's possible that we don’t know all the risks yet.
WHAT IF I DON’T QUALIFY FOR MONOCLONAL ANTIBODY TREATMENT?
Your healthcare provider may decide you don’t qualify for mAb treatment. You may not meet all of the eligibility criteria, or you may have an underlying health condition that disqualifies you for mAb treatment.
Don’t give up, there could be another options. You may be able to join a clinical trial for COVID-19. Participants in these clinical trials may receive new drugs or other treatments, so scientists can evaluate how well the treatments work. Thousands of participants in clinical trials have helped with the discovery of new treatments for COVID-19 are needed to ensure treatments work for people across age, gender, race, and ethnicity.
Stay safe. Mask. Social distance. Frequent hand washing. Avoid crowds.
ALWAYS CONSULT YOUR PERSONAL HEALTH CARE PROFESSIONAL
1756 N. Riverside Ave
Rialto, CA 92376
Phone: 909 879-1059
Fax : 909 879-1043
Monday 10 am - 4:00 pm Tuesday 10 am - 4:00 pm
Wednesday 10 am - 4:00 pm
Thursday 10 am - 4:00 pm
Friday 10 am - 4:00 pm
HOLIDAY HOURS MAY VARY
10:30 am - 3 pm
Phone orders are encouraged. Large orders prior to 10:30 am
Deliveries not available during covid restrictions.
Stop in to check out all the items currently discounted for your personal resolutions.